Put Options

20 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2022

Aug 08, 2022

SELL
$3.17 - $6.17 $634 - $1,234
-200 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$4.16 - $13.72 $45,760 - $150,920
-11,000 Reduced 98.21%
200 $1,000
Q4 2021

Feb 14, 2022

SELL
$10.83 - $18.41 $609,729 - $1.04 Million
-56,300 Reduced 83.41%
11,200 $151,000
Q3 2021

Nov 15, 2021

BUY
$13.07 - $18.84 $882,225 - $1.27 Million
67,500 New
67,500 $1.21 Million
Q1 2021

May 17, 2021

SELL
$16.56 - $25.46 $192,095 - $295,336
-11,600 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$15.77 - $19.03 $182,932 - $220,748
11,600 New
11,600 $197,000
Q3 2020

Nov 16, 2020

SELL
$16.59 - $24.79 $82,950 - $123,950
-5,000 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$16.86 - $23.44 $256,272 - $356,288
-15,200 Reduced 75.25%
5,000 $116,000
Q1 2020

May 15, 2020

BUY
$14.47 - $27.96 $13,023 - $25,164
900 Added 4.66%
20,200 $361,000
Q4 2019

Feb 14, 2020

SELL
$15.87 - $23.12 $38,088 - $55,488
-2,400 Reduced 11.06%
19,300 $417,000
Q3 2019

Nov 14, 2019

BUY
$16.91 - $36.27 $287,470 - $616,590
17,000 Added 361.7%
21,700 $395,000
Q2 2019

Aug 14, 2019

BUY
$31.0 - $36.3 $3,100 - $3,629
100 Added 2.17%
4,700 $167,000
Q1 2019

May 15, 2019

SELL
$31.58 - $46.35 $18,948 - $27,810
-600 Reduced 11.54%
4,600 $155,000
Q4 2018

Feb 14, 2019

SELL
$30.43 - $56.65 $374,289 - $696,795
-12,300 Reduced 70.29%
5,200 $171,000
Q3 2018

Nov 14, 2018

BUY
$46.46 - $68.49 $106,858 - $157,527
2,300 Added 15.13%
17,500 $1.07 Million
Q2 2018

Aug 14, 2018

BUY
$46.25 - $104.45 $494,875 - $1.12 Million
10,700 Added 237.78%
15,200 $742,000
Q1 2018

May 15, 2018

SELL
$57.4 - $108.44 $5,740 - $10,844
-100 Reduced 2.17%
4,500 $478,000
Q4 2017

Feb 14, 2018

SELL
$23.02 - $60.5 $69,060 - $181,500
-3,000 Reduced 39.47%
4,600 $276,000
Q3 2017

Nov 14, 2017

BUY
$17.79 - $24.0 $71,160 - $96,000
4,000 Added 111.11%
7,600 $182,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,600
3,600 $72,000

Others Institutions Holding NKTR

About NEKTAR THERAPEUTICS


  • Ticker NKTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,404,992
  • Market Cap $201M
  • Description
  • Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...
More about NKTR
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.